000			01429 a2200385 4500
005			20250514010128.0
264		0	_c20010927
008			200109s 0 0 eng d
022			_a0002-953X
024	7		_a10.1176/appi.ajp.158.9.1367 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoff, D C
245	0	0	_aThe emerging role of glutamate in the pathophysiology and treatment of schizophrenia. _h[electronic resource]
260			_bThe American journal of psychiatry _cSep 2001
300			_a1367-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAnimals
650	0	4	_aAntipsychotic Agents _xpharmacology
650	0	4	_aBrain _xdrug effects
650	0	4	_aCerebral Cortex _xdrug effects
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aGlutamates _xdrug effects
650	0	4	_aHumans
650	0	4	_aLimbic System _xdrug effects
650	0	4	_aRats
650	0	4	_aReceptors, Glutamate _xdrug effects
650	0	4	_aSchizophrenia _xdrug therapy
650	0	4	_aSchizophrenic Psychology
650	0	4	_aSynaptic Transmission _xdrug effects
650	0	4	_aThalamus _xdrug effects
700	1		_aCoyle, J T
773	0		_tThe American journal of psychiatry _gvol. 158 _gno. 9 _gp. 1367-77
856	4	0	_uhttps://doi.org/10.1176/appi.ajp.158.9.1367 _zAvailable from publisher's website
999			_c11456572 _d11456572